Mayaro Virus: An Emerging Alphavirus in the Americas

Journal article : Review

Mayaro virus (MAYV) is an arbovirus first isolated in Trinidad and Tobago in 1954. MAYV is the causative agent of Mayaro fever, which is characterised by high fever, maculopapular rash, myalgia and arthralgia. The potential for chronic arthralgia is of particular clinical concern. Currently, MAYV outbreaks are restricted to South and Central America, with some cases reported in Africa as well as several imported cases in Europe. However, in recent years, MAYV has become a growing global concern due to its potential to emerge into urban transmission cycles. Challenges faced with diagnostics, as well as a lack of specific antivirals or licensed vaccines further exacerbate the potential global health threat posed by MAYV. In this review, we discuss this emerging arboviral threat with a particular focus on the current treatment and vaccine development efforts. Overall, MAYV remains a neglected arbovirus due to its limited area of transmission. However, with the potential of its urbanisation and expanding circulation, the threat MAYV poses to global health cannot be overlooked. Further research into the improvement of current diagnostics, as well as the development of efficacious antivirals and vaccines will be crucial to help prevent and manage potential MAYV outbreaks.

Authors: Wei, LLL; Tom, R; Kim, YC

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: MDPI
• Journal: Viruses
• Volume: 16
• Issue: 8
• Article number: 1297
• Publication date: 2024-08-14
• Acceptance date: 2024-07-31
• DOI: 10.3390/v16081297
• EISSN: 1999-4915
• Language: English
• Keywords: public health; arbovirus; alphavirus; vaccines; arthralgia; Mayaro virus
• Subtype: Review